NasdaqGS:RVMDBiotechs
Revolution Medicines Weighs Merck Interest Against Insider Selling And Risks
Revolution Medicines (NasdaqGS:RVMD) has attracted reported takeover interest from Merck, drawing fresh attention to the company and its pipeline.
The interest surfaces as Revolution Medicines insiders, including General Counsel Jeff Cislini, have recently sold shares.
Investors are weighing potential M&A activity alongside insider transactions and a sharply higher share price.
Revolution Medicines enters this phase with strong recent share price moves, with the stock at $117.63 and up...